| Bioactivity | Icrocaptide (ITF1697) is a stable Lys-Pro-containing peptide that inhibits the intracellular Ca2+-dependent fusion of Weibel-Palade bodies with the plasma membrane. Icrocaptide can be used for the study of a variety of microvascular disorders[1]. |
| CAS | 169543-49-1 |
| Sequence | Gly-(N-Et)Lys-Pro-Arg |
| Shortening | G-(N-Et)Lys-PR |
| Formula | C21H40N8O5 |
| Molar Mass | 484.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Silvia Bertuglia, et al. ITF1697, a stable Lys-Pro-containing peptide, inhibits weibel-palade body exocytosis induced by ischemia/reperfusion and pressure elevation. Mol Med. 2007 Nov-Dec;13(11-12):615-24. |
Icrocaptide
CAS: 169543-49-1 F: C21H40N8O5 W: 484.59
Icrocaptide (ITF1697) is a stable Lys-Pro-containing peptide that inhibits the intracellular Ca2+-dependent fusion of We
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.